Literature DB >> 33498726

Opioids and Sickle Cell Disease: From Opium to the Opioid Epidemic.

Samir K Ballas1.   

Abstract

Sickle cell disease (SCD) is an inherited disorder of hemoglobin structure. The clinical effects of the sickle gene are pleiotropic in nature causing multiple phenotypic expressions associated with the various complications of the disease. The hallmark of the disease is pain that could be acute, chronic, nociceptive, or neuropathic that could occur singly or in various combinations. The acute vaso-occlusive painful crisis (VOC) is the most common cause of admissions to the Emergency Department and/or the hospital. Although progress has been made in understanding the pathophysiology of SCD as well as in developing preventive and curative therapies, effective pain management continues to lag behind and depend mostly on the use of opioids. This review describes the history of opioids from the ancient times of opium to the current use of the many controversial opioids. In addition, the major cause of death of patients with SCD is the complications of the disease itself and not the use of opioids. The use of opioids by patients with SCD has been stable over the years. Judicious use of opioids to treat sickle cell pain according to available guidelines could minimize the unnecessary suffering experienced by patients with SCD.

Entities:  

Keywords:  epidemic; mortality; opioids; opium; pandemic; sickle cell disease

Year:  2021        PMID: 33498726      PMCID: PMC7865837          DOI: 10.3390/jcm10030438

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  55 in total

1.  Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.

Authors:  Fergus D Law; Alison M Diaper; Jan K Melichar; Simon Coulton; David J Nutt; Judy S Myles
Journal:  J Psychopharmacol       Date:  2017-06-20       Impact factor: 4.153

2.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

Review 3.  The gut-brain interaction in opioid tolerance.

Authors:  Hamid I Akbarali; William L Dewey
Journal:  Curr Opin Pharmacol       Date:  2017-11-13       Impact factor: 5.547

Review 4.  The impact of opioid-induced hyperalgesia for postoperative pain.

Authors:  Wolfgang Koppert; Martin Schmelz
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2007-03

5.  Physicians' attitude and practices in sickle cell disease pain management.

Authors:  Elise Labbé; Donald Herbert; Johnson Haynes
Journal:  J Palliat Care       Date:  2005       Impact factor: 2.250

6.  The physiological disposition and fate of meperidine (demerol) in man and a method for its estimation in plasma.

Authors:  J J BURNS; B L BERGER; P A LIEF; A WOLLACK; E M PAPPER; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1955-07       Impact factor: 4.030

7.  Structure of the δ-opioid receptor bound to naltrindole.

Authors:  Sébastien Granier; Aashish Manglik; Andrew C Kruse; Tong Sun Kobilka; Foon Sun Thian; William I Weis; Brian K Kobilka
Journal:  Nature       Date:  2012-05-16       Impact factor: 49.962

8.  Structure of the human κ-opioid receptor in complex with JDTic.

Authors:  Huixian Wu; Daniel Wacker; Mauro Mileni; Vsevolod Katritch; Gye Won Han; Eyal Vardy; Wei Liu; Aaron A Thompson; Xi-Ping Huang; F Ivy Carroll; S Wayne Mascarella; Richard B Westkaemper; Philip D Mosier; Bryan L Roth; Vadim Cherezov; Raymond C Stevens
Journal:  Nature       Date:  2012-03-21       Impact factor: 49.962

9.  Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic.

Authors:  Aaron A Thompson; Wei Liu; Eugene Chun; Vsevolod Katritch; Huixian Wu; Eyal Vardy; Xi-Ping Huang; Claudio Trapella; Remo Guerrini; Girolamo Calo; Bryan L Roth; Vadim Cherezov; Raymond C Stevens
Journal:  Nature       Date:  2012-05-16       Impact factor: 49.962

10.  Platelet-derived growth factor receptor-β antagonism restores morphine analgesic potency against neuropathic pain.

Authors:  Courtney L Donica; Yan Cui; Shanping Shi; Howard B Gutstein
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

View more
  1 in total

Review 1.  Opioid Use in Patients With Sickle Cell Disease During a Vaso-Occlusive Crisis: A Systematic Review.

Authors:  Hadia Arzoun; Mirra Srinivasan; Isra Sahib; Jack Fondeur; Lisbeth Escudero Mendez; Raneem K Hamouda; Lubna Mohammed
Journal:  Cureus       Date:  2022-01-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.